Anecortave Acetate in Patients With Open-angle Glaucoma

• Status: Completed
• Trial end date: 2008-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety, efficacy, and duration of effect of a single administration of Anecortave Acetate Depot for treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Anecortave; Hydrocortisone

Criteria

Inclusion Criteria:

• Patients 18 years of age or older with open-angle glaucoma.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Patients with open-angle glaucoma with a pseudoexfoliation or pigment dispersion component.

• Other protocol-defined exclusion criteria may apply.